BDBM426466 ((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-yloxy)piperidin-1-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US10526336, Example 85

SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Oc1nccn2nccc12

InChI Key InChIKey=HSJPFTYVSRGKPB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 426466   

TargetOrexin receptor type 2(Human)
Merck, Sharp & Dohme

US Patent
LigandPNGBDBM426466(US10526336, Example 85 | ((2R,5R)-2-methyl-5-(pyra...)
Affinity DataIC50: 15.5nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck, Sharp & Dohme

US Patent
LigandPNGBDBM426466(US10526336, Example 85 | ((2R,5R)-2-methyl-5-(pyra...)
Affinity DataIC50: 1.50E+3nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
US Patent